Reappearance of Helicobacter pylori after eradication:: Implications on duodenal ulcer recurrence -: A prospective 6 year study

被引:19
作者
Archimandritis, A
Balatsos, V
Delis, V
Manika, Z
Skandalis, N
机构
[1] Univ Athens, Sch Med, Dept Pathophysiol, Gastroenterol Sect, Athens, Greece
[2] Gen State Hosp Athens, Dept Gastroenterol, Athens, Greece
[3] Gen State Hosp Athens, Dept Pathol, Athens, Greece
关键词
eradication; duodenal ulcer; follow-up; Helicobacter pylori; omeprazole; ranitidine; reappearance of H-pylori; recrudescence; recurrence; reinfection; classic triple eradication therapy; ulcer relapse;
D O I
10.1097/00004836-199906000-00012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We estimated the rate of Helicobacter pylori "reappearance" and of duodenal ulcer relapse up to 6 years after eradication of H, pylori. Of 220 patients in whom H. pylori was eradicated, 165 were eligible at 12 months to follow-up. Endoscopy was scheduled every 12 months or whenever symptoms appeared. Baseline H. pylori eradication was confirmed by CLO test, histology (hematoxylin-eosin and Giemsa stain), and culture. H. pylori was tested for by the three methods at 12 months and subsequently by 2 methods (CLO, histology) on biopsies obtained from the gastric antrum and body. We reviewed 90 patients after 1 year, 32 after 2 years, 13 after 3 years, 12 after 4 years, 2 after 5 years, and 16 after 6 years (range, 12 to 72 months; average, 25.23 months; patient-years, 347). At 12 months after eradication, 16 of 165 patients (9.7%) were H. pylori positive and 5 had ulcer relapse, Of 75 patients evaluated at 24 months, 7 (9.3%) were H. pylori positive and 1 (1.3%) had ulcer relapse. At 36 months, 43 patients were seen and 1 (2.3%) was H. pylori positive and had ulcer relapse (2.3%). Thirty, 18, and 16 patients were seen at 48, 60, and 72 months, respectively. None was H. pylori positive and none had ulcer relapse. Overall, 24 H. pylori-positive patients were found, two thirds of them in the first year after eradication. In 7 of 24 (29%, 6 smokers), ulcer recurred. None of the H. pylori-negative patients had ulcer relapse. The H, pylori reappearance rate was 7% and the ulcer relapse rate was 2% per patient-year. If the 16 H. pylori-positive patients who were found the first year are considered as recrudescence, then the reinfection rate will be 2.3% per patient-year.
引用
收藏
页码:345 / 347
页数:3
相关论文
共 12 条
[1]  
AbuMahfouz MZ, 1997, AM J GASTROENTEROL, V92, P2025
[2]   HELICOBACTER-PYLORI INFECTION IN GREECE IN HEALTHY PEOPLE AND IN PATIENTS WITH PEPTIC-ULCER AND WITH DYSPEPSIA WITHOUT ULCER [J].
ARCHIMANDRITIS, A ;
BITSIKAS, J ;
TJIVRAS, M ;
FERTAKIS, A ;
ANASTASAKOU, E ;
PITSOUNI, E ;
MARINIS, E ;
DAVARIS, P .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1993, 16 (03) :257-258
[3]   TRIPLE THERAPY ERADICATED HELICOBACTER-PYLORI EQUALLY IN PATIENTS PRETREATED WITH OMEPRAZOLE OR RANITIDINE - A 12-MONTH FOLLOW-UP [J].
ARCHIMANDRITIS, A ;
BALATSOS, V ;
DELIS, V ;
MENTIS, A ;
KASTANAS, K ;
SCANDALIS, N .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (01) :12-16
[4]   Helicobacter pylori reinfection after apparent eradication - The Ipswich experience [J].
Bell, GD ;
Powell, KU .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 :96-104
[5]  
BELL GD, 1993, Q J MED, V86, P375
[6]  
BORODY TJ, 1994, AM J GASTROENTEROL, V89, P529
[7]   Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy [J].
Miehlke, S ;
Lehn, N ;
Meining, A ;
Bastlein, E ;
Mannes, GA ;
Stolte, M ;
Bayerdorffer, E .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1996, 8 (12) :1161-1163
[8]   Reinfection versus recrudescence in Helicobacter pylori infection [J].
vanderEnde, A ;
vanderHulst, RWM ;
Dankert, J ;
Tytgat, GNJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 :55-61
[9]   Prevention of ulcer recurrence after eradication of Helicobacter pylori: A prospective long-term follow-up study [J].
vanderHulst, RWM ;
Rauws, EAJ ;
Koycu, B ;
Keller, JJ ;
Bruno, MJ ;
Tussen, JGP ;
Tytgat, GNJ .
GASTROENTEROLOGY, 1997, 113 (04) :1082-1086
[10]  
VANDERHULST RWM, 1996, GASTROENTEROLOGY, V110, pA284